Partial Deletion of the MAPT Gene: A Novel Mechanism of FTDP-17

被引:33
|
作者
Rovelet-Lecrux, Anne [1 ]
Lecourtois, Magalie [1 ]
Thomas-Anterion, Catherine [2 ]
Le Ber, Isabelle [3 ]
Brice, Alexis [3 ]
Frebourg, Thierry [1 ]
Hannequin, Didier [1 ]
Campion, Dominique [1 ]
机构
[1] Fac Med, Inserm U614, F-76183 Rouen, France
[2] CHU, Dept Neurol, F-42055 St Etienne, France
[3] Univ Paris 06, INSERM, Hop La Salpetriere, UMR S679,AP HP, F-75013 Paris, France
关键词
MAPT; deletion; FTDP-17; MAP-1B; FAMILIAL FRONTOTEMPORAL DEMENTIA; TAU-PROTEIN; MICROTUBULE-BINDING; HYPERPHOSPHORYLATED TAU; ALZHEIMERS-DISEASE; MUTATIONS; CELLS; ISOFORMS; DEGENERATION; TAUOPATHIES;
D O I
10.1002/humu.20979
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A heterozygous genomic deletion removing exons 6 to 9 of the microtubule associated protein tau (MAPT) gene, predicting to result into a truncated protein lacking the first microtubule binding domain, was detected in a patient with frontotemporal dementia (FTD). Cell culture experiments showed that the truncated tau isoforms had a dramatic decrease in the normal binding to microtubules but acquired the ability to bind microtubule associated protein-1B (MAP-1B). This indicates that this tauopathy likely results both from a loss of function mechanism and from a deleterious gain of function by which cytoplasmic deleted forms of tau sequester another MAP. Both mechanisms could contribute to impair microtubule dynamics. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:E591 / E602
页数:12
相关论文
共 50 条
  • [11] Rest in peace FTDP-17
    Josephs, Keith A.
    BRAIN, 2018, 141 : 324 - 326
  • [12] FTDP-17 associated with the MAPT P301L mutation and severe brainstem pathology
    Gener, M. A. H.
    Murrell, J. R.
    Oblak, A. L.
    Ghetti, B.
    BRAIN PATHOLOGY, 2014, 24 : 70 - 70
  • [13] Phenotypic correlations in FTDP-17
    Reed, LA
    Wszolek, ZK
    Hutton, M
    NEUROBIOLOGY OF AGING, 2001, 22 (01) : 89 - 107
  • [14] Olfactory dysfunction in FTDP-17/PPND
    Schweitzer, Katherine J.
    Dickson, Dennis W.
    Stongosky, Audrey
    Hentschel, Kenneth
    Williams, Lindsey
    Wszolek, Zbigniezv K.
    ANNALS OF NEUROLOGY, 2008, 64 : S49 - S49
  • [15] Gene expression and proteomic profiles of FTDP-17: Preliminary analyses
    Murrell, Jill
    Schweitzer, Kelly
    McClintick, Jeanette
    Decker, Emily
    Spina, Salvatore
    Wang, Mu
    Edenberg, Howard
    Ghetti, Bernardino
    BRAIN PATHOLOGY, 2006, 16 : S45 - S45
  • [16] INTER- AND INTRAFAMILIAL CLINICAL HETEROGENEITY IN FTDP-17 ASSOCIATED WITH MAPT 10+16 MUTATION
    Larner, A. J.
    Doran, M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [17] Dephosphorylation of FTDP-17 mutant tau
    Asada, Akiko
    Yotsumoto, Kensuke
    Saito, Taro
    Oikawa, Takayuki
    Ishiguro, Koichi
    Uchida, Takafumi
    Hasegawa, Masato
    Hisanaga, Shin-Ichi
    NEUROSCIENCE RESEARCH, 2008, 61 : S263 - S263
  • [18] The genetics of PSP/CBD and FTDP-17
    Hutton, M
    MOVEMENT DISORDERS, 2002, 17 (06) : 1402 - 1403
  • [19] Pick's complex and FTDP-17
    Kertesz, A
    MOVEMENT DISORDERS, 2003, 18 : S57 - S62
  • [20] FTDP — 17 without parkinsonism in family with the tau gene (MAPT) mutation
    Małgorzata Chodakowska-Żebrowska
    Anna Barczak
    Mariusz Berdyński
    Jolanta Sikorska
    Maria Barcikowska
    Pharmacological Reports, 2009, 61 (6) : 1225 - 1225